Rein Therapeutics (RNTX) Current Liabilities

Annual Current Liabilities

$4.38 M
+$1.00 M+29.58%

December 1, 2023


Summary


Performance

RNTX Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRNTXbalance sheetmetrics:

Quarterly Current Liabilities

$5.66 M
+$722.00 K+14.62%

September 1, 2024


Summary


Performance

RNTX Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherRNTXbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

RNTX Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+29.6%+24.9%
3 y3 years+10.7%+96.2%
5 y5 years-18.3%-12.0%

RNTX Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.7%-22.8%at high-78.8%
5 y5-year-24.9%-22.8%-7.9%-78.8%
alltimeall time-24.9%-41.9%-20.4%-78.8%

Rein Therapeutics Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$5.66 M(+14.6%)
Jun 2024
-
$4.94 M(+8.9%)
Mar 2024
-
$4.53 M(+3.4%)
Dec 2023
$4.38 M(+29.6%)
$4.38 M(+170.0%)
Sep 2023
-
$1.62 M(+35.7%)
Jun 2023
-
$1.20 M(-58.5%)
Mar 2023
-
$2.88 M(-14.8%)
Dec 2022
$3.38 M(-24.9%)
$3.38 M(-25.4%)
Sep 2022
-
$4.54 M(-11.9%)
Jun 2022
-
$5.15 M(+24.2%)
Mar 2022
-
$4.15 M(-8.0%)
Dec 2021
$4.51 M(+13.8%)
$4.51 M(-1.1%)
Sep 2021
-
$4.56 M(+6.7%)
Jun 2021
-
$4.27 M(+39.0%)
Mar 2021
-
$3.07 M(-22.4%)
Dec 2020
$3.96 M
$3.96 M(-24.6%)
DateAnnualQuarterly
Sep 2020
-
$5.25 M(+6.6%)
Jun 2020
-
$4.93 M(-19.8%)
Mar 2020
-
$6.14 M(+5.2%)
Dec 2019
$5.84 M(+8.7%)
$5.84 M(-9.2%)
Sep 2019
-
$6.43 M(+19.3%)
Jun 2019
-
$5.39 M(+16.5%)
Mar 2019
-
$4.62 M(-13.9%)
Dec 2018
$5.37 M(+9.8%)
$5.37 M(-24.4%)
Sep 2018
-
$7.11 M(+11.6%)
Jun 2018
-
$6.36 M(+31.1%)
Mar 2018
-
$4.86 M(-0.7%)
Dec 2017
$4.89 M(+20.1%)
$4.89 M(-2.6%)
Sep 2017
-
$5.02 M(-8.2%)
Jun 2017
-
$5.47 M(+90.6%)
Mar 2017
-
$2.87 M(-29.5%)
Dec 2016
$4.07 M(+59.7%)
$4.07 M
Dec 2015
$2.55 M
-

FAQ

  • What is Rein Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Rein Therapeutics?
  • What is Rein Therapeutics annual current liabilities year-on-year change?
  • What is Rein Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Rein Therapeutics?
  • What is Rein Therapeutics quarterly current liabilities year-on-year change?

What is Rein Therapeutics annual total current liabilities?

The current annual current liabilities of RNTX is $4.38 M

What is the all time high annual current liabilities for Rein Therapeutics?

Rein Therapeutics all-time high annual total current liabilities is $5.84 M

What is Rein Therapeutics annual current liabilities year-on-year change?

Over the past year, RNTX annual total current liabilities has changed by +$1.00 M (+29.58%)

What is Rein Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of RNTX is $5.66 M

What is the all time high quarterly current liabilities for Rein Therapeutics?

Rein Therapeutics all-time high quarterly total current liabilities is $7.11 M

What is Rein Therapeutics quarterly current liabilities year-on-year change?

Over the past year, RNTX quarterly total current liabilities has changed by +$1.13 M (+24.87%)